Boston Scientific Completes Enrollment in EVOLVE Clinical Trial

Boston Scientific Corporation Monday announced the completion of patient enrollment in the EVOLVE clinical trial, which is designed to assess the safety and performance of the Company’s fourth-generation SYNERGY Coronary Stent.
CNBC